Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

Market Cap	3.09B +47.1%
Revenue (ttm)	319.72M +3.4%
Net Income	16.46M +70.2%
EPS	0.13 +59.4%
Shares Out	119.99M
PE Ratio	194.74
Forward PE	n/a
Dividend	0.10 (0.39%)
Ex-Dividend Date	Sep 25, 2025

Volume	3,382,969
Average Volume	2,847,947
Open	25.52
Previous Close	25.42
Day's Range	25.39 - 26.70
52-Week Range	14.13 - 42.25
Beta	1.50
RSI	52.55
Earnings Date	Apr 29, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 797
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300813

Financial Performance

In 2024, SHE:300813's revenue was 349.00 million, an increase of 29.33% compared to the previous year's 269.86 million. Earnings were 13.05 million, a decrease of -33.65%.